Transient inhibitors in the Recombinate PUP study.
Rothschild
C
C
Gill
J
J
Scharrer
I
I
Bray
G
G
D005169:Factor VIII / Q000008:administration & dosage / Q000009:adverse effects* / Q000276:immunology; D006467:Hemophilia A / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D007518:Isoantibodies / Q000096:biosynthesis* / Q000145:classification; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000009:adverse effects / Q000276:immunology; D013997:Time Factors; D016896:Treatment Outcome
D007518:Isoantibodies; D011994:Recombinant Proteins; C078147:F8 protein, human; D005169:Factor VIII